Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Meliha Çağla SÖNMEZER"'
Autor:
A. Rasheed BAHAR, Yasemin BAHAR, Serkan UYSAL, Meliha Çağla SÖNMEZER, Dolunay GÜLMEZ, Sevgen ÇELİK ÖNDER, Mehmet Ruhi ̇ONUR, Sevtap ARIKAN AKDAĞLI, Ahmet ÇAĞKAN İNKAYA, Dilara İNAN, Serhat ÜNAL
Publikováno v:
Mediterranean Journal of Infection, Microbes and Antimicrobials, Vol 11, Iss 1 (2022)
Opportunistic infections remain as an important cause of morbidity and mortality in patients with human immunodeficiency virus (HIV), predominantly in patients who are not receiving antiretroviral therapy. On the other hand, the evaluation and manage
Externí odkaz:
https://doaj.org/article/222488df1fdc4a95ba05b13fa4bf1c40
Autor:
Gülçin Telli Dizman, Gökhan Metan, Gizem Karahan, Elif Seren Tanrıverdi, Gülşen Hazırolan, Barış Otlu, Meliha Çağla Sönmezer, Nur Dilek Gül, Burcu Çınar, Serhat Ünal
Publikováno v:
Infection Control & Hospital Epidemiology. :1-3
An outbreak investigation was initiated after detecting an increase in the number of patients with Stenotrophomonas maltophilia bloodstream infections (SM-BSIs) througout the hospital. S. maltophilia was isolated from the cultures of blood-gas ınjec
Autor:
Zahit Taş, Meliha Çağla Sönmezer, Gülçin Telli Dizman, Ahmet Çağkan İnkaya, Ömrüm Uzun, Murat Akova
Publikováno v:
Acta Medica. 53:299-302
A 74-year-old female from a rural district in Central Anatolia, Turkey, was admitted with persisting fever, malaise, cough, and vomiting. There is no abnormal finding on physical examination. There was no petechiae, purpura, ecchymosis, or bleeding i
Autor:
Ömrüm Uzun, Sevilay Karahan, Nursel Çalık Başaran, Gülçin Telli Dizman, Meliha Çağla Sönmezer, Oğuz Abdullah Uyaroğlu
Publikováno v:
Acta Medica. 53:73-82
Objectives: In this study, we compared the clinical outcomes and effects of the treatments on laboratory parameters between patients who were treated with favipiravir (FAV) or hydroxychloroquine plus azithromycin (HCQ/AZ) for COVID-19 pneumonia in no
Publikováno v:
Turkiye Klinikleri Journal of Case Reports. 30:40-43
Autor:
Hakan Göker, Olgu Erkin Çınar, Rashad Ismayilov, Ela Özdemir, Ümit Yavuz Malkan, Elifcan Aladağ Karakulak, Yahya Büyükaşık, Nilgün Sayınalp, İbrahim C. Haznedaroğlu, Osman Özcebe, Gülçin Telli Dizman, Meliha Çağla Sönmezer, Ahmet Çağkan İnkaya, Haluk Demiroğlu
Publikováno v:
Acta Medica.
Objective: We aimed to delineate the effects of the ABO groups and the main clinical outcomes with the current SARS-CoV-2 variants, i.e., delta and omicron. Materials and Methods: In this retrospective case-control study, the total 360 adult COVID-19
Publikováno v:
Turkish Journal of Medical Sciences
Due to the COVID-19 infection, which was recognized as a global pandemic by the WHO on March 11, 2020, the number of cases and disease-related deaths increases day by day globally. For this reason, antiviral agents used in treatment and vaccines, the
Publikováno v:
Flora the Journal of Infectious Diseases and Clinical Microbiology. 26:361-368
SARS-CoV-2 genetic variants from alpha (first detected in the UK) to delta (discovered in India this spring) to lambda (currently Argentina, Brazil, Chile, Colombia, Ecuador, and Peru) have been emerging and circulating the world. Also, these variant
Publikováno v:
Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Vol 26, Iss 3, Pp 361-368 (2021)
SARS-CoV-2 genetic variants from alpha (first detected in the UK) to delta (discovered in India this spring) to lambda (currently Argentina, Brazil, Chile, Colombia, Ecuador, and Peru) have been emerging and circulating the world. Also, these variant
Publikováno v:
Flora the Journal of Infectious Diseases and Clinical Microbiology. 26:227-231
The number of cases and disease-dependent deaths continue to increase worldwide due to the COVID-19 infection accepted as a global pandemic by the World Health Organization on March 11, 2020. Therefore, the antivirals used in treatment and vaccines t